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Materials and Methods 
Protein preparation and crystallization: Fe-protein and MoFe-protein from Azotobacter 
vinelandii were isolated and purified under anaerobic conditions as described previously.1 
Crystals of the pcp/adp-complex were prepared under conditions similar to the pcp-complex2 in 
sitting drops by vapor diffusion in an anaerobic chamber at room temperature, using solutions 
and chemicals that were thoroughly deaerated using vacuum/Ar-fill cycles. Precipitating 
solutions contained 18-22% PEG 8000 (w/v), in addition to 0-50 mM NaCl, 100 mM Tris buffer 
(pH 8.5), and 10 mM sodium dithionite. The protein solutions were prepared by mixing 
appropriate amounts of Fe-protein and MoFe-protein stock solutions ([Fe-protein]stock= ~40 
mg/ml, [MoFe-protein]stock= ~20 mg/ml), which were in 100 mM Tris (pH 7.75), 200 mM 
NaCl and 5 mM dithionite. Complex cocrystals were obtained using 1:1.2 to 1:1.5 MoFe-
protein:Fe-protein ratios (v/v), corresponding to ~4 to 6-fold molar excess of Fe-protein per 
active site of MoFe-protein. The protein solutions also contained 10 mM MgCl2, 5 mM 
AMPPCP and 5 mM ADP, whose stock solutions (100 mM) were prepared in 100 mM Tris 
buffer (pH 8.5) immediately prior to setting up the crystallization trays. The crystallization drops 
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contained 2 µl of the precipitating solution and 2 µl of the protein mixture, and the reservoir 
contained 250-500 µl of the precipitating solution.  
 
Crystallography: For the collection of X-ray diffraction data, suitable crystals were exchanged 
into 25% PEG 400 in five steps over one hour for cryoprotection and flash-frozen in liquid 
nitrogen. X-ray diffraction data were collected at ALS (BL 8.2.1) using 1.0-Å radiation. Data 
collection and refinement statistics are summarized in Table S1. Data sets were processed using 
XDS3 and AIMLESS.4 The initial phases were obtained by molecular replacement using 
MOLREP5 with MoFe-protein (PDB ID 1M1N) as a search model. Initial electron density maps 
clearly revealed the positions of the iron-sulfur clusters and most secondary structure elements of 
Fe-protein molecules, allowing their manual placement using the ADP•AlF4- complexed Fe-
protein (PDB ID 1M34)6 as the model. After an initial round of rigid-body refinement with CNS7 
and manual rebuilding with MAIN,8 the model was refined with PHENIX9 with alternating 
rounds of manual rebuilding in MAIN and COOT.10 The stereochemistry of the final model was 
calculated using MOLPROBITY11 as implemented in PHENIX. Final refinement statistics are 
given in Table S1.  For consistency, the pdp-complex structure2 (PDB ID 2AFK) was re-refined 
against the original diffraction data using the same protocol, with final refinement statistics listed 
in Table S2.  Figures were prepared using PYMOL.12  
Simulated annealing omit maps were calculated by phenix.refine (Fig S1), using the final 
coordinate file with all nucleotides and magnesium-water molecules deleted, applying the default 
values for cartesian simulated annealing and automated torsion NCS. Final R/R-free values were 
0.153/0.195. 
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Principal Components Analysis 
A principal components analysis (PCA) of the conformational changes relating a set of 21 Fe-
protein coordinates (Table S3) was conducted using methods developed by Berendsen and 
coworkers.13,14 For these calculations, a reference Fe-protein dimer (chain IDs E and F of PDB 
ID 1N2C) was transformed so that the molecular two-fold axis was positioned on the z axis of an 
orthogonal coordinate frame (by convention, the chain IDs of the two Fe-protein subunits in a 
dimer are (A, B) for free Fe-protein and (E, F), (G, H), (M, N) and (O, P) when complexed with 
MoFe-protein, where E, G, M, O primarily interact with the alpha-subunit).  One subunit (chain 
ID equal to A, E, G, M or O) from each of the 20 other Fe-protein dimers was then superimposed 
onto chain E of the reference Fe-protein dimer. The PCA was then used to identify the directions 
associated with the largest concerted movement of atoms (ie, the principal components) that best 
describe the relationships between the second subunits (ie corresponding to chain IDs B, F, H, N 
or P). The α-carbons of residues 6-49, 70-115, 120-125, 129-186 and 193-260 (222/289 
residues) were used for the superposition; residues in flexible or more highly variable regions 
were excluded to emphasize the rigid body type motions. 
 
The basic algorithm involves the calculation of the covariance matrix of the fluctuations of each 
atomic coordinate from the average value of the corresponding coordinate in Fe-protein subunits 
with chain IDs B, F, H, N or P: 
Cij = xi,k ! xi,ave( ) x j ,k ! x j ,ave( )
k=1
Nmol
"
j=1
3Nres
"
i=1
3Nres
"  
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The eigenvectors of this matrix are directions in a 3Nres-dimensional space (where Nres is the 
number of residues = 222 (the factor of 3 accounts for the individual x, y and z components) and 
Nmol is the number of molecules = 21); motions along an eigenvector represent concerted 
fluctuations of residues. The eigenvalues are the sum of the squared deviations of the system for 
each eigenvector. The value of an eigenvalue relative to the total squared displacement of all 
structures from the average indicates the proportion of the total deviation contributed by that 
eigenvector. 
 
 
The displacement of the kth structure along the jth eigenvector is given by the projection: 
qj ,k = xi,k ! xi,ave( ) " eigvec i, j( )
i=1
3Nres
#
qj ,k = rms " Nres
 
To calculate the rigid body rotation/transformation corresponding to the jth eigenvector, the 
displacement along that eigenvector corresponding to the structure k with the largest value of qj,k 
is calculated; this displacement is added to the reference structure and the rigid body 
transformation calculated by an algorithm described by Kabsch.15 
 
The components along the top 3 eigenvectors calculated for the PCA of Fe-protein 
conformations are tabulated in Table S3.  The rotation axes corresponding to eigenvectors 1 and 
2 (EV1 and EV2) are depicted in text Figure 3.  The sum of the squared displacements of all 222 
residues in the 21 structures from the average of all their positions is 82,441 Å2; the projections 
along EV1 and EV2 account for 72,617 Å2 (88%) and 5,430 Å2 (~7%), respectively, so that the 
contribution from all the remaining eigenvectors is ~5%.  
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EV1 corresponds to a hinge bending motion as the two Fe-protein subunits qualitatively move 
approximately perpendicular to the dimer interface, while EV2 corresponds to a twisting motion 
as the Fe-protein subunits move approximately parallel to the dimer interface relative to one 
another. For this calculation, a translation of 2 Å along an eigenvector corresponds to ~5˚ 
rotation about the corresponding rotation axis. The hinge angle is the rotation angle required to 
relate F/B/N/P subunits to that of 1N2C subunit F (the original alf-complex structure) when 
E/A/M/O subunits are all superimposed on subunit E of 1N2C. Consequently, the reference state 
is the alf-complex and the hinge rotation is defined relative to that state.  In Figure 3, the distance 
between the alf-complexes and the nucleotide free Fe-protein is ~10 Å along component 1, 
which corresponds to ~25˚ rotation to relate these two conformations, as is observed for the 
hinge angle. 
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Table S1.  Data collection and refinement statistics for the pcp/adp-complex* 
 
PDB Accession Code 
Wavelength (Å) 
4WZA 
1.000 
Resolution range (Å) 19.8  - 1.9 (1.967  - 1.9) 
Space group P 21 21 21 
Unit cell (a, b, c (Å)) 110.201, 120.412, 264.318 
Total reflections 973,682 (69,288) 
Unique reflections 269,423 (24,317) 
Multiplicity 3.6 (2.8) 
Completeness (%) 97.8 (87.8) 
Mean I/sigma(I) 13.6 (2.1) 
Wilson B-factor 19.80 
R-merge 0.078 (0.550) 
R-work 0.145 (0.236) 
R-free 0.186 (0.281) 
Number of non-hydrogen atoms 26,664 
 macromolecules 24,234 
 ligands 246 
 water 2,184 
Protein residues 3,110 
rms bonds (Å) 0.010 
rms angles (˚) 1.51 
Ramachandran outliers (%) 0.36 
Clashscore 2.31 
Average B-factor (Å2) 28.9 
 macromolecules 28.4 
 ligands 24.2 
 solvent 34.9 
 
*Statistics for the highest-resolution shell are shown in parentheses. 
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Table S2.  Refinement statistics for the re-refined 2AFK pcp-complex* 
 
PDB Accession Code 
Resolution range (Å) 
4WZB 
49.38  - 2.2 (2.279  - 2.2) 
Space group  P 21 21 21 
Unit cell (a, b, c (Å)) 110.533, 120.894, 264.834 
Reflections used for R-free  
R-work 0.193 (0.243) 
R-free 0.254 (0.312) 
Number of non-hydrogen atoms 25,159 
   macromolecules 23,976 
   ligands 240 
   water 943 
Protein residues 3,064 
rms bonds (Å) 0.011 
rms angles (˚) 1.62 
Ramachandran favored (%) 97 
Ramachandran outliers (%) 0.49 
Clashscore 6.89 
Average B-factor (Å2) 37.6 
   macromolecules 37.8 
   ligands 31.8 
   solvent 33.5 
 
*Statistics for the highest-resolution shell are shown in parentheses. 
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Table S3 - Principal Components Analysis of Fe-protein conformation 
 
set structure 
ref FeP 
subunit EV1 (Å) EV2 (Å) EV3 (Å) 
hinge 
angle (˚) 
1 1N2C/alf E 5.93 0.84 -0.43 0 
2 1M34/alf E 5.73 0.81 -0.39 0.3 
3 1M34/alf G 5.65 0.88 -0.33 0.4 
4 1M34/alf M 5.62 0.83 -0.35 0.5 
5 1M34/alf O 5.69 0.91 -0.41 0.5 
6 pcp E 2.91 -0.64 2.02 10.8 
7 pcp G 2.14 -1.40 0.88 10.9 
8 pcpadp E 2.46 -1.17 0.91 11.0 
9 pcpadp G 1.96 -1.40 0.76 11.1 
10 2AFI/adp E -0.84 -1.19 -1.49 17.1 
11 2AFI/adp G -1.84 -0.76 -0.17 19.8 
12 2AFI/adp M -3.15 1.88 -0.32 26.4 
13 2AFI/adp O -2.12 -1.87 -0.73 20.8 
14 1FP6/adp A -1.34 -1.54 -0.97 18.4 
15 2NIP/wt A -3.39 0.05 -0.81 25.1 
16 1G5P/wt A -3.39 0.04 -0.81 25.1 
17 2AFH/nf E -4.58 -0.12 0.29 27.9 
18 1M1Y/xlink E -4.48 0.90 0.47  
19 1M1Y/xlink G -4.52 1.02 0.46  
20 1M1Y/xlink M -4.12 1.00 0.68  
21 1M1Y/xlink O -4.32 0.92 0.74  
 
EV1, EV2 and EV3 are the components along the top 3 eigenvectors calculated from the PCA of 
Fe-protein conformations.  The rotation axes corresponding to EV1 and EV2 are depicted in text 
Figure 3.  EV1 corresponds to a hinge bending motion as the two Fe-protein subunits 
qualitatively move either towards or away from the dimer interface, while EV2 corresponds to a 
twisting motion as the Fe-protein subunits move along the interface. For this calculation, a 
translation of 2 Å along an eigenvector corresponds to ~5˚ rotation about the corresponding 
rotation axis. 
 
Coordinate sets are identified by PDB ID; sets 1-13 and 17-21 are Fe-proteins complexed to 
MoFe-protein (alf = alf-complex;6,16 pcp = pcp-complex and pcpadp = pcp/adp-complex (this 
work); adp = adp-complex2; 1FP6 = free Av2 complexed to ADP;17 wt = wildtype Av2;18,19 nf = 
nucleotide free-Av2 complexed to Av1;2 and xlink =  Av2 chemically crosslinked to Av16 ) 
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Figure S1. Simulated-annealing, omit Fo–Fc electron densities of Mg.AMPPCP and Mg.ADP 
nucleotides contoured at 4.0 σ. 
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Figure S2. Glu154, Arg187 and Arg213 are observed to form alternative and mutually exclusive 
sets of inter- and intra-subunit salt bridges16,18 that could serve to differentially stabilize the Fe-
protein subunits in defined conformations with distinct subunit-subunit orientations. Glu154 
exhibits three distinct sets of interactions, forming intersubunit salt bridges to Arg213 in the alf-
complex, to Arg187 in the pcp- and pcp/adp-complexes, and an intrasubunit saltbridge to Arg 
187 in the ADP state.  An intriguing aspect of these interactions are the presence of various types 
of arginine stacking interactions, including the prominent Adenine-Arg213-Arg187-Arg187-
Arg213-Adenine stack observed in the pcp/adp-complex structure; while stacking of 
guanidinium groups would be expected to be electrostatically unfavorable, several recent studies 
have highlighted the frequency of their occurrence, suggesting that the overall energetics are 
stabilizing.20,21 
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